These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Synthesis and relative potencies of new constrained CRF antagonists. Hernandez JF; Kornreich W; Rivier C; Miranda A; Yamamoto G; Andrews J; Taché Y; Vale W; Rivier J J Med Chem; 1993 Oct; 36(20):2860-7. PubMed ID: 8411001 [TBL] [Abstract][Full Text] [Related]
10. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. Martínez V; Rivier J; Wang L; Taché Y J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288 [TBL] [Abstract][Full Text] [Related]
14. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats. Martínez V; Rivier J; Taché Y J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571 [TBL] [Abstract][Full Text] [Related]
15. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. Beyermann M; Fechner K; Furkert J; Krause E; Bienert M J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists. Rijkers DT; den Hartog JA; Liskamp RM Bioorg Med Chem; 2004 Oct; 12(19):5099-106. PubMed ID: 15351393 [TBL] [Abstract][Full Text] [Related]
17. An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists. Rijkers DT; den Hartog JA; Liskamp RM Biopolymers; 2002 Feb; 63(2):141-9. PubMed ID: 11787002 [TBL] [Abstract][Full Text] [Related]
18. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism. Dautzenberg FM; Wille S Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833 [TBL] [Abstract][Full Text] [Related]
19. Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist. Rivier J; Gulyas J; Kunitake K; DiGruccio M; Cantle JP; Perrin MH; Donaldson C; Vaughan J; Million M; Gourcerol G; Adelson DW; Rivier C; Taché Y; Vale W J Med Chem; 2007 Apr; 50(7):1668-74. PubMed ID: 17335188 [TBL] [Abstract][Full Text] [Related]
20. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Rivier C; Rivier J; Lee S Brain Res; 1996 May; 721(1-2):83-90. PubMed ID: 8793087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]